Cases 1 - 10 of 62
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme Corp. v. Anchen Pharmaceuticals, Inc., et al.
as 1:2019cv00311
Defendant:
Par Pharmaceuticals, Inc. and Anchen Pharmaceuticals, Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Noden Pharma DAC v. Anchen Pharmaceuticals, Inc. et al
as 1:2017cv00728
Plaintiff:
Noden Pharma DAC
Defendant:
Anchen Pharmaceuticals, Inc. and Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Forest Laboratories, LLC et al v. Lupin Limited et al
as 1:2014cv01058
Plaintiff:
Forest Laboratories, LLC , Forest Laboratories Holdings Ltd. and Adamas Pharmaceuticals Inc.
Defendant:
Lupin Limited , Lupin Pharmaceuticals Inc. , Par Pharmaceutical Inc. and others
Counter_claimant:
Lupin Pharmaceuticals Inc. , Lupin Limited , Anchen Pharmaceuticals Inc. and others
Counter_defendant:
Adamas Pharmaceuticals Inc. , Forest Laboratories Holdings Ltd. and Forest Laboratories, LLC
Cause Of Action: 35 U.S.C. § 271
Forest Laboratories Inc. et al v. Apotex Corp. et al
as 1:2014cv00200
Plaintiff:
Forest Laboratories Inc. , Forest Laboratories Holdings Ltd. and Adamas Pharmaceuticals Inc.
Defendant:
Apotex Corp. , Apotex Inc. , Zydus Pharmaceuticals (USA) Inc. and others
Cause Of Action: 35 U.S.C. § 271
Sucampo AG et al v. Anchen Pharmaceuticals Inc. et al
as 1:2013cv00202
Plaintiff:
Sucampo AG , Sucampo Pharmaceuticals Inc. , R-Tech Ueno Ltd. and others
Defendant:
Anchen Pharmaceuticals Inc. , Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc et al v. Anchen Pharmaceuticals Inc et al
as 2:2012cv05535
Defendant:
Anchen Inc and Anchen Pharmaceuticals Inc
Plaintiff:
PF Prims C V, Pfizer Inc, Wyeth LLC and others
Pfizer Inc. et al v. Anchen Pharmaceuticals Inc. et al
as 1:2012cv00808
Plaintiff:
Pfizer Inc. , Wyeth LLC , Wyeth Pharmaceuticals Inc. and others
Defendant:
Anchen Pharmaceuticals Inc. and Anchen Inc.
Cause Of Action: 35 U.S.C. § 271
Plaintiff v. Defendant
as 4:2012cv00999
Plaintiff:
Plaintiff v. Defendant
Defendant:
Plaintiff v. Defendant
Cause Of Action: 28 U.S.C. § 1332
ASTRAZENECA AB et al v. ANCHEN PHARMACEUTICALS, INC.
as 3:2011cv06348
Plaintiff:
ASTRAZENECA AB , ASTRAZENECA LP , KBI-E INC. and others
Defendant:
ANCHEN PHARMACEUTICALS, INC.
Counter_claimant:
ANCHEN PHARMACEUTICALS, INC.
Counter_defendant:
ASTRAZENECA AB , ASTRAZENECA LP , KBI-E INC. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
